Inventor
KOGAN TIMOTHY P
US20 patents
⚠️ This page may combine multiple inventors who share the name “KOGAN TIMOTHY P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TEXAS BIOTECHNOLOGY CORP
11 patentsUS5510332AApr 23, 1996
Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor
TEXAS BIOTECHNOLOGY CORP151 citations97
US6194448B1Feb 27, 2001
N, N-disubstituted amides that inhibit the binding of integrins to their receptors
TEXAS BIOTECHNOLOGY CORP42 citations95
US5783705AJul 21, 1998
Process of preparing alkali metal salys of hydrophobic sulfonamides
TEXAS BIOTECHNOLOGY CORP48 citations95
US5622937AApr 22, 1997
Compositions and methods of inhibiting the binding of E-selectin or P-selectin or sialyl-Lewisx or sialyl-Lewisa
TEXAS BIOTECHNOLOGY CORP56 citations94
US5444050AAug 22, 1995
Binding of E-selectin or P-selectin to sialyl Lewisx or sialyl-Lewisa
TEXAS BIOTECHNOLOGY CORP93 citations94
US5919768AJul 6, 1999
Di- and trivalent small molecule selectin inhibitors
TEXAS BIOTECHNOLOGY CORP61 citations92
US6262084B1Jul 17, 2001
Compounds that inhibit the binding of integrins to their receptors
TEXAS BIOTECHNOLOGY CORP18 citations91
US6087330AJul 11, 2000
Process to inhibit binding of the integrin α4 β1 to VCAM-1 or fibronectin and cyclic peptides therefor
TEXAS BIOTECHNOLOGY CORP33 citations91
US5776907AJul 7, 1998
Mitomycin oligonucleotide conjugates
TEXAS BIOTECHNOLOGY CORP21 citations88
US5712387AJan 27, 1998
High yield stereospecific mannosylation
TEXAS BIOTECHNOLOGY CORP8 citations74
US6713604B1Mar 30, 2004
Process to inhibit binding of the integrin α4β1 , to VCAM-1 fibronectin and cyclic peptides thereof
TEXAS BIOTECHNOLOGY CORP7 citations72
GENENTECH INC
8 patentsUS5889155AMar 30, 1999
Carbohydrate-directed cross-linking reagents
GENENTECH INC83 citations97
US5329028AJul 12, 1994
Carbohydrate-directed cross-linking reagents
GENENTECH INC87 citations97
US5250732AOct 5, 1993
Ketamine analogues for treatment of thrombocytopenia
GENENTECH INC60 citations95
US6582928B1Jun 24, 2003
Carbohydrate-directed cross-linking reagents
GENENTECH INC16 citations92
US5384331AJan 24, 1995
Ketamine analogues for treatment of thrombocytopenia
GENENTECH INC43 citations92
US6124435ASep 26, 2000
Carbohydrate-directed cross-linking reagents
GENENTECH INC10 citations82
US5929211AJul 27, 1999
Carbohydrate-directed cross-linking reagents
GENENTECH INC11 citations82
US5605791AFeb 25, 1997
Carbohydrate-directed cross-linking reagents
GENENTECH INC6 citations73